Detection reagent kit for methylation of septin 9 genes in human peripheral blood circulation tumor DNA

A kit and methylation technology, applied in the biological field, can solve the problems of insufficient screening rate, false positive enzyme, large sample size, etc., and achieve the effect of improving sensitivity and reliability, simple operation and good specificity.

Active Publication Date: 2016-02-17
湖南宏雅基因技术有限公司
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In China, the screening rates of fecal occult blood test and colonoscopy are estimated to be less than 5% and 3% respectively
This is a classic methylation research method. Its advantages are: relatively simple, low cost, clear methylation sites, and easy interpretation of experimental results. The disadvantages are: 1. Since CG is not limited to CCGG sequences, it is not The CG in this sequence will be ignored; 2. Only when the methylation status of key sites related to transcription is detected, the results of this detection method are meaningful; 3. Relatively speaking, the Southern method is more complicated and requires The amount of sample is large; 4. There is a problem of false positives caused by incomplete enzyme digestion; 5. It is not suitable for mixed samples

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection reagent kit for methylation of septin 9 genes in human peripheral blood circulation tumor DNA
  • Detection reagent kit for methylation of septin 9 genes in human peripheral blood circulation tumor DNA
  • Detection reagent kit for methylation of septin 9 genes in human peripheral blood circulation tumor DNA

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Materials: Plasma samples to be tested, positive quality control products, and negative quality control products. The positive quality control product is fully methylated human genomic DNA modified by bisulfite, and the negative quality control product is non-methylated human genomic DNA modified by bisulfite.

[0064] A detection kit for the methylation of the septin9 gene in human peripheral blood circulating tumor DNA, including: methylation-specific primers for the target site of the septin9 gene; non-methylation-specific dideoxycytidine-modified primers for the target site of the septin9 gene; The hydrolysis probe specific to the septin9 gene; the primer of the internal reference gene and the hydrolysis probe of the internal reference gene; the target site of the septin9 gene is at least one CpG site contained in the gamma 1 exon region of the septin9 gene V2 transcript; the internal reference The gene is one or more of GAPDH, β-actin, B2M, SDHA, and HPRT1.

[006...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a detection reagent kit for methylation of septin 9 genes in human peripheral blood circulation tumor DNA. The detection reagent kit comprises methylation-specific primers for target loci of the septin 9 genes, non-methylation-specific dideoxycytidine modified primers for the target loci of the septin 9 genes, hydrolysis probes specific to the septin 9 genes, primers for reference genes and hydrolysis probes for the reference genes, wherein the target loci of the septin 9 genes are at least one CpG locus contained in an exon region of transcripts gamma 1 of the septin 9 genes V2, and the reference genes are one or more of GAPDH, beta-actin, B2M, SDHA and HPRT1. By means of the component configuration scheme and the result interpretation scheme of the reagent kit, the detection process is easy and convenient, and operability is high. Detection results are reliable, and specificity is good.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a kit for detecting methylation of septin9 gene in human peripheral blood circulating tumor DNA. Background technique [0002] Colorectal cancer is one of the major diseases that cause human death worldwide. In Europe and the United States, colorectal cancer ranks second and third, respectively. In 2012, there were about 447,000 new cases of colorectal cancer in Europe, and about 215,000 deaths. In 2013, the number of new cases in the United States was about 142,820 people, and about 50,830 deaths. In China, the number of new cases of colorectal cancer in 2012 was about 400,000, and it has become the disease with the third highest morbidity and mortality among Chinese people. [0003] Early detection of colorectal cancer can be achieved through routine screening, and early treatment can be carried out to prevent the progression of the disease or even cure it. However, t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 贺毅憬刘杨彭艳肖飞虞健涂超峰
Owner 湖南宏雅基因技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products